Verzenio 150 mg/1

Verzenio 150 mg tablets contain abemaciclib, a medication used in cancer treatment. This oral tablet is manufactured by Eli Lilly and Company in the USA.

Verzenio 150 mg tablets are generally used in the treatment of certain types of cancer. Abemaciclib is often prescribed as part of a broader cancer treatment plan, including advanced breast cancer. Patients should consult their healthcare provider to understand the specific uses of abemaciclib in their treatment regimen.

Common effects of Verzenio 150 mg tablets may include fatigue, nausea, and diarrhea. Some users might experience a decrease in appetite or hair loss. It's important to discuss any persistent or severe effects with a healthcare professional.

Verzenio 150 mg tablets should be handled with care and stored as directed. This medication may cause drowsiness, so it's advisable to avoid driving or operating heavy machinery until you know how it affects you. Always follow the guidance of your healthcare provider regarding the use of abemaciclib.

Verzenio 150 mg tablets may interact with certain medications, including those metabolized by the liver. It's important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with your healthcare provider to avoid potential interactions.